While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

Some of the best stocks on the market once traded at less than $5 a share. Look at Advanced Micro Devices. Back in 2016, the ...

Researchers have found in a new research that higher dietary niacin intake was associated with lower all-cause mortality risk ...

Discover an informative webinar featuring leading researchers as they discuss advancements in biomarker discovery for Alzheimer's disease (AD) and related dementias. This webinar will showcase how the ...

Disease modification for Alzheimer's disease is now a reality. Trials of two immunotherapies targeting amyloid b—lecanemab1 and donanemab2—have had positive outcomes, and regulatory approval in ...

Huntington's disease is a rare genetic, autosomal dominant, neurodegenerative disease, caused by CAG repeat expansions in the HTT gene, that is polymorphic on the healthy allele and contains more than ...

Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “overweight” rating reissued by research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday,Benzinga reports. A ...

Zhang, X. and Zeng, X. (2025) Diagnostic Challenges and Multidisciplinary Management Strategies for Manicure-Induced ...

Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a ...